Isentress - what's more important for MRK is to get it approved for treatment-naive and data look very good there.
Agreed. Approval in the first line is essential if the drug is ever going to exceed $1B in annual sales.
If qD Isentress ends up working as well as BID, Isentress could be a very big-selling drug; however (as stated in #msg-35447718), I consider the qD trial a long shot. We’ll know the answer in late 2011 or early 2012.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.